Relationship Between Computed Tomography Imaging Features and Clinical Characteristics, Masaoka-Koga Stages, and World Health Organization Histological Classifications of Thymoma

Xiaowei Han, Wenwen Gao, Yue Chen, Lei Du, Jianghui Duan, Hongwei Yu, Runcai Guo, Lu Zhang, Guolin Ma, Xiaowei Han, Wenwen Gao, Yue Chen, Lei Du, Jianghui Duan, Hongwei Yu, Runcai Guo, Lu Zhang, Guolin Ma

Abstract

Objectives: Computed tomography (CT) is an important technique for evaluating the condition and prognosis of patients with thymomas, and it provides guidance regarding treatment strategies. However, the correlation between CT imaging features, described using standard report terms, and clinical characteristics, Masaoka-Koga stages, and World Health Organization (WHO) classifications of patients with thymomas has not been described in detail nor has risk factor analysis been conducted. Methods: Overall, 159 patients with thymomas who underwent preoperative contrast-enhanced CT between September 2011 and December 2018 were retrospectively reviewed. We assessed the clinical information, CT imaging features, and pathological findings for each patient. A total of 89 patients were specially used to evaluate postoperative recurrence or metastasis between September 2011 and December 2015 to obtain an appropriate observation period. The relationship between CT imaging features and clinical characteristics, Masaoka-Koga stage, and WHO histological classification were analyzed, and related risk factors based on CT imaging features were identified. Results: CT imaging features did not significantly differ based on sex or age. Some imaging features demonstrated significant differences between the groups with and without related clinical characteristics. Contour (odds ratio [OR] = 3.711, P = 0.005), abutment ≥50% (OR = 4.277, P = 0.02), and adjacent lung abnormalities (OR = 3.916 P = 0.031) were independent risk factors for relapse or metastasis. Among all imaging features, there were significant differences between stage I/II and III/IV lesions in tumor size, calcification, infiltration of surrounding fat, vascular invasion, pleural nodules, elevated hemidiaphragm, and pulmonary nodules. Tumor size (odds ratio = 1.261, P = 0.014), vascular invasion (OR = 2.526, P = 0.023), pleural nodules (OR = 2.22, P = 0.048), and pulmonary nodules (OR = 3.106, P = 0.006) were identified as independent risk factors. Tumor size, contour, internal density, infiltration of surrounding fat, and pleural effusion significantly differed between low- and high-risk thymomas. Tumor size (OR = 1.183, P = 0.048), contour (OR = 2.288, P = 0.003), internal density (OR = 2.192, P = 0.024), and infiltration of surrounding fat (OR = 2.811 P = 0.005) were independent risk factors. Conclusions: Some CT imaging features demonstrated significant correlations with clinical characteristics, Masaoka-Koga clinical stages, and WHO histological classifications in patients with thymomas. Familiarity with CT features identified as independent risk factors for these related clinical characteristics can facilitate preoperative evaluation and treatment management for the patients with thymoma.

Keywords: Masaoka–Koga stage; WHO histological classification; computed tomography; myasthenia gravis; thymoma.

Copyright © 2019 Han, Gao, Chen, Du, Duan, Yu, Guo, Zhang and Ma.

Figures

Figure 1
Figure 1
Tumor size and pleural effusion are associated with patient's symptoms. (A) Axial contrast-enhanced chest CT image obtained at the level of the aortic arch showed a small thymoma with a smooth contour (Masaoka–Koga stage I and WHO classification A), which was first found at the time of physical examination in a 49-year-old woman. (B) A 53-year-old man with chief complains of cough, chest pain symptoms. Axial contrast-enhanced chest CT image obtained at the level of below the aortic arch showed a larger thymoma with lobulated contour and infiltration of surrounding fat (arrows), accompanied with left pleural effusion (Masaoka–Koga stage III and WHO classification B2).
Figure 2
Figure 2
Masaoka–Koga stage II thymomas. (A) Axial contrast-enhanced chest CT image showed a thymoma with a clear contour (Masaoka–Koga stage IIa and WHO classification B1), which was first found at the time of physical examination in a 55-year-old woman. (B) A 50-year-old woman mainly complains of general fatigue and subsequently was confirmed myasthenia gravis. Axial contrast-enhanced chest CT image obtained at the level of the left pulmonary trunk showed a thymoma with a slight lobulated contour (Masaoka–Koga stage IIb and WHO classification AB).
Figure 3
Figure 3
A multi-lobulated heterogeneous thymoma with vascular invasion. Axial contrast-enhanced chest CT image obtained at the level of the aortic arch demonstrated a thymoma in a 54-year-old man complained of bosom frowsty and chest pain (Masaoka–Koga stage III and WHO classification B1). The lesion directly invaded the left brachiocephalic vein (A, white arrow). The tumor showed the heterogeneous attenuation distributions and multi-lobulated contour (A,B, arrow head), the aortic arch was pushed backward.
Figure 4
Figure 4
A heterogeneous thymoma accompanied with pleural nodule. (A) Axial contrast-enhanced chest CT image obtained at the level of the pulmonary trunk demonstrated a multi-lobulated thymoma with internal multiple calcification lesions (white arrow) in a 69-year-old man with myasthenia gravis (Masaoka–Koga stage IVa and WHO classification B3). (B) Showed the adjacent thickened pleura (red arrow head) and pleural nodule (white arrow head).
Figure 5
Figure 5
A thymoma with infiltration of surrounding fat and lymph node enlargement. Axial contrast-enhanced chest CT image obtained at the level of the pulmonary trunk demonstrated a thymoma in a 49-year-old man (Masaoka–Koga stage IVb and WHO classification B3). (A,B) Showed the thickened pleura (red arrow head), infiltration of surrounding fat (white arrows), and bulging margin (white arrow head). The lymph node enlargement appeared at the superior level of the lesion (A, red arrow) and at the level of left hilum (B, red arrow).
Figure 6
Figure 6
The schematic diagram of CT imaging features as risk factors for clinical characteristics, Masaoka–Koga stage, and WHO histological classification. The X-axis displayed the CT imaging features and Y-axis indicated the clinical characteristics, Masaoka–Koga stage, and WHO histological classification. The ratio of occurrence frequency of one imaging feature was quantitatively calculated in one subgroup and size of ratio value was represented by color bar (With and without relapse or metastasis were based on a total of 89 patients). The circle and oval circle showed the imaging features as risk factors for the related clinical characteristics, Masaoka–Koga stage, and WHO histological classification. The single star (*) indicated the significant difference (P < 0.05) and the double stars (**) indicated the significant difference (P < 0.01) by the binary logistic regression analysis.

References

    1. Marom EM. Advances in thymoma imaging. J Thorac Imaging. (2013) 28:69–80; quiz:81–3. 10.1097/RTI.0b013e31828609a0
    1. Yanagawa M, Tomiyama N. Prediction of thymoma histology and stage by radiographic criteria. Thorac Surg Clin. (2010) 21:1–12. 10.1016/j.thorsurg.2010.08.008
    1. Marom EM. Imaging thymoma. J Thorac Oncol. (2010) 5(10 Suppl. 4):S296–303. 10.1097/JTO.0b013e3181f209ca
    1. Narahari NK, Gongati PK, Kakarla B, Nizami MI, Boddula RP, Sattavarapu LR. Thymoma-associated immunodeficiency: a diagnostic challenge for the clinician. Asian Cardiovasc Thorac Ann. (2017) 25:146–9. 10.1177/0218492316687934
    1. Toro J, Cuellar-Giraldo D, Duque A, Minota K, Patiño J, García M. Seronegative paraneoplastic limbic encephalitis associated with thymoma. Cogn Behav Neurol. (2017) 30:125–8. 10.1097/WNN.0000000000000134
    1. Hayes SA, Huang J, Plodkowski AJ, Katzen J, Zheng J, Moskowitz CS, et al. . Preoperative computed tomography findings predict surgical resectability of thymoma. J Thorac Oncol. (2014) 9:1023–30. 10.1097/JTO.0000000000000204
    1. Zhao Y, Chen H, Shi J, Fan L, Hu D, Zhao H. The correlation of morphological features of chest computed tomographic scans with clinical characteristics of thymoma. Eur J Cardiothorac Surg. (2015) 48:698–704. 10.1093/ejcts/ezu475
    1. Luo T, Zhao H, Zhou X. The clinical features, diagnosis and management of recurrent thymoma. J Cardiothorac Surg. (2016) 11:140. 10.1186/s13019-016-0533-9
    1. Dong D, Tang L, Li ZY, Fang MJ, Gao JB, Shan XH, et al. . Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. (2019) 30:431–8. 10.1093/annonc/mdz001
    1. Liu Z, Li Z, Qu J, Zhang R, Zhou X, Li L, et al. . Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study. Clin Cancer Res. (2019) 25:3538–47. 10.1158/1078-0432.CCR-18-3190
    1. Beckers PAJ, Mercelis R, Heyman S, Verheuen L, Lauwers P, Hendriks JM, et al. . Myasthenia gravis appearing after thymectomy heralding recurrent thymoma. Acta Chir Belg. (2019) 119:195–7. 10.1080/00015458.2018.1438556
    1. Hakiri S, Kawaguchi K, Fukui T, Nakamura S, Ozeki N, Mori S, et al. . Verification of the diagnostic strategy for anterior mediastinal tumors. Int J Clin Oncol. (2019) 24:385–93. 10.1007/s10147-018-1362-8
    1. Kato T, Iwano S, Taniguchi T, Kawaguchi K, Fukui T, Ishiguro F, et al. . The contact length between the tumor contour and the lung on computed tomography is a risk factor for pleural recurrence after complete resection of thymoma. Gen Thorac Cardiovasc Surg. (2015) 63:343–8. 10.1007/s11748-015-0525-z
    1. Do YW, Lee HJ, Narm KS, Jung HS, Lee JG, Kim DJ, et al. . Tumor perimeter and lobulation as predictors of pleural recurrence in patients with resected thymoma. Lung Cancer. (2016) 98:79–83. 10.1016/j.lungcan.2016.05.017
    1. Pandey S, Jaipal U, Mannan N, Yadav R. Diagnostic accuracy of multidetector computed tomography scan in mediastinal masses assuming histopathological findings as gold standard. Pol J Radiol. (2018) 83:e234–42. 10.5114/pjr.2018.76709
    1. Klimiec E, Quirke M, Leite MI, Hilton-Jones D. Thymus imaging in myasthenia gravis: the relevance in clinical practice. Muscle Nerve. (2018) 58:153–6. 10.1002/mus.26096
    1. Luo H, Xie S, Ma C, Zhang W, Tschöpe C, Fa X, et al. . Correlation between thymus radiology and myasthenia gravis in clinical practice. Front Neurol. (2019) 9:1173. 10.3389/fneur.2018.01173
    1. Green DB, Eliades S, Legasto AC, Askin G, Port JL, Gruden JF. Multilobulated thymoma with an acute angle: a new predictor of lung invasion. Eur Radiol. (2019) 29:4555–62. 10.1007/s00330-019-06059-1
    1. Okumura M, Yoshino I, Yano M, Watanabe SI, Tsuboi M, Yoshida K, et al. . Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. Eur J Cardiothorac Surg. (2019) 56:174–81. 10.1093/ejcts/ezz001
    1. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, et al. . Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol. (2011) 6:1274–81. 10.1097/JTO.0b013e31821c4203
    1. Ozawa Y, Hara M, Shimohira M, Sakurai K, Nakagawa M, Shibamoto Y. Associations between computed tomography features of thymomas and their pathological classification. Acta Radiol. (2016) 57:1318–25. 10.1177/0284185115590288
    1. Yano M, Sasaki H, Moriyama S, Hikosaka Y, Okuda K, Shitara M, et al. . Clinicopathological analysis of small-sized anterior mediastinal tumors. Surg Today. (2014) 44:1817–22. 10.1007/s00595-013-0727-x
    1. Tomiyama N, Müller NL, Ellis SJ, Cleverley JR, Okumura M, Miyoshi S, et al. . Invasive and noninvasive thymoma: distinctive CT features. J Comput Assist Tomogr. (2001) 25:388–93. 10.1097/00004728-200105000-00010
    1. Tomiyama N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, et al. . Using the World Health Organization classification of thymic epithelial neoplasms to describe CT findings. AJR Am J Roentgenol. (2002) 179:881–6. 10.2214/ajr.179.4.1790881
    1. Khandelwal A, Sholl LM, Araki T, Ramaiya NH, Hatabu H, Nishino M. Patterns of metastasis and recurrence in thymic epithelial tumours: longitudinal imaging review in correlation with histological subtypes. Clin Radiol. (2016) 71:1010–7. 10.1016/j.crad.2016.05.007
    1. Choe J, Lee SM, Lim S, Choi SH, Kim N, Do KH, et al. . Doubling time of thymic epithelial tumours on CT: correlation with histological subtype. Eur Radiol. (2017) 27:4030–6. 10.1007/s00330-017-4795-y
    1. Marom EM, Rosado-de-Christenson ML, Bruzzi JF, Hara M, Sonett JR, Ketai L. Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma. J Thorac Oncol. (2011) 6(7 Suppl. 3):S1717–23. 10.1097/JTO.0b013e31821e8cd6
    1. Scorsetti M, Leo F, Trama A, D'Angelillo R, Serpico D, Macerelli M, et al. . Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. (2016) 99:332–50. 10.1016/j.critrevonc.2016.01.012
    1. Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol. (2010) 5:2017–23. 10.1097/JTO.0b013e3181f13682
    1. Blagev DP, Lloyd JF, Conner K, Dickerson J, Adams D, Stevens SM, et al. . Follow-up of incidental pulmonary nodules and the radiology report. J Am Coll Radiol. (2016) 13(Suppl. 2):R18–24. 10.1016/j.jacr.2015.12.008
    1. Detterbeck FC, Moran C, Huang J, Suster S, Walsh G, Kaiser L, et al. . Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol. (2011) 6(7 Suppl. 3):S1730–8. 10.1097/JTO.0b013e31821ea567
    1. Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol. (2011) 6(7 Suppl. 3): S1710–6. 10.1097/JTO.0b013e31821e8cff
    1. Liang G, Gu Z, Li Y, Fu J, Shen Y, Wei Y, et al. . Comparison of the Masaoka-Koga staging and the International Association for the study of lung cancer/the International Thymic Malignancies Interest Group proposal for the TNM staging systems based on the Chinese Alliance for Research in Thymomas retrospective database. J Thorac Dis. (2016) 8:727–37. 10.21037/jtd.2016.03.22
    1. Carter BW, Benveniste MF, Madan R, Godoy MC, Groot PM, Truong MT, et al. . IASLC/ITMIG staging system and lymph node map for thymic epithelial neoplasms. Radiographics. (2017) 37:758–76. 10.1148/rg.2017160096
    1. Carter BW, Benveniste MF, Madan R, Godoy MC, de Groot PM, Truong MT, et al. . ITMIG classification of mediastinal compartments and multidisciplinary approach to mediastinal masses. Radiographics. (2017) 37:413–36. 10.1148/rg.2017160095
    1. Xie Y, Zhang S, Liu J, Liang X, Zhang X, Zhang Y, et al. . Value of CT spectral imaging in the differential diagnosis of thymoma and mediastinal lymphoma. Br J Radiol. (2019) 92:20180598. 10.1259/bjr.20180598
    1. Kong LY, Zhang W, Zhou Y, Xu H, Shi HB, Feng Q, et al. . Histogram analysis of apparent diffusion coefficient maps for assessing thymic epithelial tumours: correlation with world health organization classification and clinical staging. Br J Radiol. (2018) 91:20170580. 10.1259/bjr.20170580
    1. Hwang Y, Park IK, Park S, Kim ER, Kang CH, Kim YT. Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations. J Thorac Oncol. (2016) 11:108–14. 10.1016/j.jtho.2015.09.001
    1. Ried M, Eicher MM, Neu R, Sziklavari Z, Hofmann HS. Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival. World J Surg Oncol. (2017) 15:214. 10.1186/s12957-017-1283-4
    1. Nakayama H, Kase M, Imada T, Osqwa H, Mukai K, Yamagata T, et al. . A clinicopathologic study of thymomas: a review of 52 cases, with particular reference to results of treatment. Kyobu Geka. (1993) 46:13–20.
    1. Shen Y, Ye J, Fang W, Zhang Y, Ye X, Ma Y, et al. . Efficacy of computed tomography features in predicting stage III thymic tumors. Oncol Lett. (2017) 13:29–36. 10.3892/ol.2016.5429
    1. Ried M, Marx A, Götz A, Hamer O, Schalke B, Hofmann HS. State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma. Eur J Cardiothorac Surg. (2016) 49:1545–52. 10.1093/ejcts/ezv426
    1. Benveniste MF, Korst RJ, Rajan A, Detterbeck FC, Marom EM, International Thymic Malignancy Interest Group . A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol. (2014) 9(9 Suppl. 2):S119–24. 10.1097/JTO.0000000000000296
    1. Fujimoto K, Hara M, Tomiyama N, Kusumoto M, Sakai F, Fujii Y. Proposal for a new mediastinal compartment classification of transverse plane images according to the Japanese Association for Research on the Thymus (JART) general rules for the study of mediastinal tumors. Oncol Rep. (2014) 31:565–72. 10.3892/or.2013.2904
    1. Bhora FY, Chen DJ, Detterbeck FC, Asamura H, Falkson C, Filosso PL, et al. . The ITMIG/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors. J Thorac Oncol. (2014) 9(9 Suppl. 2):S88–96. 10.1097/JTO.0000000000000293
    1. Gochi F, Omasa M, Yamada T, Sato M, Menju T, Aoyama A, et al. . Factors affecting the preoperative diagnosis of anterior mediastinal cysts. Gen Thorac Cardiovasc Surg. (2015) 63:349–53. 10.1007/s11748-015-0530-2
    1. Ackman JB, Verzosa S, Kovach AE, Louissaint A, Jr, Lanuti M, Wright CD, et al. . High rate of unnecessary thymectomy and its cause. Can computed tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts? Eur J Radiol. (2015) 84:524–33. 10.1016/j.ejrad.2014.11.042
    1. Romeo V, Esposito A, Maurea S, Camera L, Mainenti PP, Palmieri G, et al. . Correlative imaging in a patient with cystic thymoma: CT, MR and PET/CT comparison. Pol J Radiol. (2015) 80:22–6. 10.12659/PJR.892105
    1. Shimamoto A, Ashizawa K, Kido Y, Hayashi H, Nagayasu T, Kawakami A, et al. . CT and MRI findings of thymic carcinoid. Br J Radiol. (2017) 90:20150341. 10.1259/bjr.20150341
    1. Priola AM, Priola SM, Giraudo MT, Gned D, Fornari A, Ferrero B, et al. . Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival. Eur Radiol. (2016) 26:2126–38. 10.1007/s00330-015-4031-6
    1. Johnson GB, Aubry MC, Yi ES, Koo CW, Jenkins SM, Garces YI, et al. . Radiologic response to neoadjuvant treatment predicts histologic response in thymic epithelial tumors. J Thorac Oncol. (2017) 12:354–67. 10.1016/j.jtho.2016.09.118
    1. Huang K, Shojania K, Chapman K, Amiri N, Dehghan N, Mezei M. Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: a case series and literature review. Semin Arthritis Rheum. (2019) 48:745–51. 10.1016/j.semarthrit.2018.05.004
    1. Omata S, Ozawa Y, Nakagawa M, Hara M, Shibamoto Y. Useful computed tomography features for differentiating between focal atelectasis and pleural dissemination on preoperative evaluations of thymic epithelial tumors. Eur J Radiol. (2018) 103:38–43. 10.1016/j.ejrad.2018.04.001
    1. Priola AM, Priola SM. Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor. Clin Radiol. (2014) 69:e230–45. 10.1016/j.crad.2014.01.005
    1. Nakazono T, Yamaguchi K, Egashira R, Takase Y, Nojiri J, Mizuguchi M, et al. . CT-based mediastinal compartment classifications and differential diagnosis of mediastinal tumors. Jpn J Radiol. (2019) 37:117–34. 10.1007/s11604-018-0777-5
    1. Zhang W, Zhou Y, Xu XQ, Kong LY, Xu H, Yu TF, et al. . A whole-tumor histogram analysis of apparent diffusion coefficient maps for differentiating thymic carcinoma from lymphoma. Korean J Radiol. (2018) 19:358–65. 10.3348/kjr.2018.19.2.358
    1. Natsag J, Tomiyama N, Inoue A, Mihara N, Johkoh T, Sumikawa H, et al. . Preoperative assessment of thymic veins on multidetector row CT: optimization of contrast material volume. Radiat Med. (2007) 25:202–10. 10.1007/s11604-007-0125-7
    1. Peng H, Dong D, Fang MJ, Li L, Tang LL, Chen L, et al. . Prognostic value of deep learning PET/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma. Clin Cancer Res. (2019) 25:4271–9. 10.1158/1078-0432.CCR-18-3065
    1. Wang S, Shi J, Ye Z, Dong D, Yu D, Zhou M, et al. . Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning. Eur Respir J. (2019) 53:1800986. 10.1183/13993003.00986-2018
    1. Sato Y, Yanagawa M, Hata A, Enchi Y, Kikuchi N, Honda O, et al. . Volumetric analysis of the thymic epithelial tumors: correlation of tumor volume with the WHO classification and Masaoka staging. J Thorac Dis. (2018) 10:5822–32. 10.21037/jtd.2018.09.133
    1. Song J, Shi J, Dong D, Fang M, Zhong W, Wang K, et al. . A new approach to predict progression-free survival in stage IV EGFR-mutant NSCLC patients with EGFR-TKI therapy. Clin Cancer Res. (2018) 24:3583–92. 10.1158/1078-0432.CCR-17-2507

Source: PubMed

3
Iratkozz fel